Amicogen (아미코젠)
KOSDAQ · KRX: 092040
Amicogen Inc. is a South Korean biotechnology company that specializes in industrial enzyme development and production, serving sectors including food, beverage, pharmaceutical, and chemical industries. The company is listed on the KOSDAQ market and operates through research and development of enzyme solutions for various commercial applications.
Filing timeline
mediumspotted 11:23 KST
Amicogen (KRX: 092040)- Chair Shin Yong-chul (신용철), registered executive, held 4,526,048 shares as of filing date 26 February 2025
- Stake decreased by 2,404,583 shares, representing a 4.37% reduction in his shareholding
- Current ownership stands at 8.23% of issued capital following the reduction
View original DART filing ↗mediumspotted 10:50 KST
Amicogen (KRX: 092040)- Chairman Shin Yong-cheol (신용철) holds 4,526,048 shares of Amicogen as of filing date 26 February 2025
- Shareholding represents 8.23% of company equity
- Share position decreased by 2,404,583 shares (4.37% reduction) in reporting period
View original DART filing ↗mediumspotted 18:01 KST
Amicogen (KRX: 092040)View original DART filing ↗AI-generated summaries of public DART filings. May contain errors — always verify against the original (linked). Not investment advice.